Journal Article Summary

The article investigates the effectiveness of two medications, paroxetine and gabapentin, in treating patients with ulcerative colitis (UC) who are in remission but also experience symptoms similar to irritable bowel syndrome (IBS). This topic is important because many UC patients in remission still suffer from functional gastrointestinal symptoms, which can significantly affect their quality of life. Understanding how these medications can alleviate both physical and psychological symptoms in this population can help improve patient care and treatment strategies.

In this study, 97 patients with UC in remission were randomly assigned to receive either paroxetine (20 mg/day) or gabapentin (initially 100 mg/day, increasing to 300 mg/day) over three months. The researchers measured changes in anxiety, depression, IBS symptom severity, and quality of life before and after the treatment period. The results showed that patients taking paroxetine experienced significantly greater reductions in anxiety and depression, as well as improved quality of life compared to those taking gabapentin. While gabapentin did lead to some improvement in IBS symptoms, it was not as effective as paroxetine in addressing the overall psychological and functional aspects of the patients' conditions.

The study has some limitations, including its single-center design and the lack of long-term follow-up to assess symptom recurrence after treatment cessation. Additionally, the researchers did not systematically document all potential side effects, which could impact the understanding of the safety profiles of the medications used. Patients should discuss these findings with their healthcare providers to consider the best treatment options for managing their symptoms, as well as to address any concerns about side effects or the long-term management of their condition.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Safaei Farahnaz, Shahrokh Shabnam, Naderi Nosratollah, Rastegar Reyhaneh, Shamsi Alireza. Unveiling the efficacy of paroxetine and gabapentin in ulcerative colitis patients in remission with co-existing IBS-like symptoms: a single-blinded randomized clinical trial. Frontiers in Medicine 2024. DOI: 10.3389/fmed.2024.1468885. PMID: 39635600. PMCID: PMC11614664.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]